Clinical note: mlnlycke-health-care-us-a-7step-checklist-for-evaluating-wound-care-amp-117

Let me start with the honest part: I wasn't always good at this. When I took over procurement at our 220-bed regional hospital in 2019, I compared spreadsheets and picked the lowest price. That approach cost us a lot of money, a ton of staff hours, and a few heated conversations with the clinical team.

Over the past 6 years, I've managed a $430,000 annual medical supply budget, audited our 2023 spending line by line, and compared quotes from 11 different wound care and surgical product suppliers. I've documented every order in our cost tracking system. This is the checklist I use now. Seven steps. Do them in order.

This is written for anyone evaluating wound care and surgical supply vendors — whether that's a global company like Mölnlycke Health Care or a regional distributor you've never heard of.

Step 1: Define the clinical need before you talk to anyone

The biggest mistake we made early on was evaluating products before defining the problem. You need to know who will use these products, and for what, before a sales rep walks through the door.

Sit down with your clinical team and map it out. What conditions are you treating? What patient populations? What does current utilization look like?

Two populations often get overlooked, and they matter a lot for wound care purchasing:

Patients with prosthetic limbs. The residual limb sits inside a socket all day, exposed to friction, moisture, and shear. If the skin breaks down, the prosthesis becomes unwearable, and the patient goes from walking to wheelchair-bound. The dressing you choose isn't just a clinical decision — it's a functional outcome decision, with real cost implications.

Ostomy patients. If you've never worked with this population, you might ask: what is an ostomy? It's a surgically created opening on the abdomen that allows stool or urine to exit the body when the normal route isn't possible. The skin around the stoma — peristomal skin — is exposed to moisture and repeated adhesive removal. Harsh adhesives can strip skin layers and turn a manageable situation into a chronic wound.

Write all of this down before you pick up the phone. That document is the spec sheet you'll use to evaluate everything that comes next.

Step 2: Verify the company, not just the product

Mölnlycke Health Care is a company that most hospital procurement teams already have on their radar. It's a Swedish medical device manufacturer with a significant US presence — Mölnlycke Health Care US — and a broad portfolio spanning wound care dressings, surgical gloves, single-use surgical drapes and gowns, and infection prevention products. These are the kinds of supplies that keep operating rooms running safely when surgical instruments are in use.

But don't take any of that on faith. Here's what I verify for every supplier, regardless of reputation:

• FDA establishment registration and device listings — check directly at fda.gov
• ISO 13485 certification (the international quality management standard for medical devices)
• Relevant 510(k) clearances for key products
• Litigation history, especially product safety claims
• Financial stability — a financially shaky supplier becomes your problem

According to the FDA (fda.gov), a 510(k) clearance means a device has been found substantially equivalent to a legally marketed device. It's not a full approval, and it's not an endorsement of superiority. Knowing the difference between regulatory pathways makes you a better buyer.

If a vendor can't produce these documents within a day, that's a red flag. Legitimate companies make this information available immediately.

Step 3: Scrutinize the technology and the evidence behind it

Every wound care company says their products are "evidence-based." The phrase has been used so much that it's nearly meaningless. Push for specifics.

Take Mölnlycke's Safetac® silicone adhesive technology. It's a soft silicone adhesive layer that seals gently over the wound, avoids sticking to the moist wound bed, and is designed to minimize skin stripping on removal. It sounds good in a brochure. The questions I ask:

• Where are the peer-reviewed clinical studies?
• Were they independent, or solely funded by the manufacturer?
• Is there evidence specific to your setting — post-surgical wounds, peristomal skin, prosthetic limb sockets?

I'd rather spend 10 minutes asking tough questions than deal with mismatched expectations later. Companies like Mölnlycke, which have invested in clinical research, don't flinch at these questions. If a vendor hesitates or changes the subject, take that as an answer.

Step 4: Calculate total cost of ownership, not unit price

This is where procurement teams get burned most. Unit price is not cost. It never was. It never will be.

From the outside, medical supply contracting looks like a straightforward "best price wins" exercise. The reality is more complicated. True cost includes nursing time, dressing change frequency, complications, waste, and disposal.

Here's a real example from our spreadsheets. We compared two dressings for post-surgical wounds. Vendor A quoted $3.20 per dressing. Vendor B quoted $8.40. Our team leaned toward Vendor A immediately. Then we ran a 90-day utilization tracking period. The cheaper dressing needed changes every one to two days. The more expensive one stayed in place for up to four days. Once we factored in nursing time — about $1.50 per change including setup, documentation, and disposal — Vendor B was cheaper on a per-episode basis.

The surprise wasn't the price difference. It was how much hidden cost came with the "cheap" option. No line item said "extra nursing hours." But they showed up in our utilization data.

Here's the TCO method I use:

1. Material cost: unit price × expected number of dressing changes per episode
2. Nursing cost: cost per change (including setup and documentation) × number of changes
3. Complication cost: delayed discharge, readmissions, extra consults
4. Total cost per episode: the sum of all three

That complication cost is the hidden beast. A skin breakdown on a patient with a prosthetic limb can lead to a fall, a hospital stay, a failed discharge. That's not a $4 dressing problem. That's a $4,000 readmission problem hiding in the data.

Step 5: Assess supply chain reliability

A vendor that can't deliver is not a vendor. It's a liability.

My experience here is with US-based suppliers serving a regional hospital. If you're sourcing internationally or running a large academic center, your logistics landscape might look different. But the questions you ask are the same:

• What's their measured on-time delivery rate — not the sales pitch, the number?
• What's their backorder rate on the specific products you'll order?
• Do they offer consignment stock for high-usage items?
• What did they do during the 2021-2022 supply chain disruptions?

Part of me likes the idea of consolidating everything with one vendor for simplicity. Another part knows that redundancy saved us during those disruption years. We run a primary + backup strategy now. It's not the cleanest system, but it's resilient.

Step 6: Run a clinical trial, not a demo

The demo room is not reality. A trial on actual patients in your facility is the only meaningful test.

When we evaluated a new line of dressings for patients with prosthetic limbs and ostomy-related skin issues, we ran a 45-day trial across 30 patients. We set clear metrics before it began: dressing changes per week, skin condition scores, patient comfort ratings, nurse satisfaction.

The results were not what the vendor's brochure anticipated. One product looked great in the demo but performed poorly in real conditions because the application technique was more difficult. The trial data caught it.

Get feedback from the nurses. They're the ones using the product every day, and their buy-in is non-negotiable. A clinically superior product that nurses hate will end up in the supply closet and never come out.

Step 7: Write a contract you can exit

This is the most overlooked step in the entire process. Multi-year contracts are normal in hospital procurement. But every contract should include:

• A termination clause of 90 days or less
• Performance-based renewal triggers (if on-time delivery falls below X%, you can renegotiate)
• Price increase caps — we use 3-4% annually as a guideline
• A clear substitution policy for backordered products

If you can't exit in under 90 days, you don't have a contract. You have a hostage situation.

Two mistakes that will cost you

1. Chasing the lowest quote. In 2020, we signed with a supplier that came in 15% below our incumbent. The products were fine. Not great, not terrible. Serviceable. But their customer service was unreachable, delivery dates slipped, and 8 months later we were running a whole new procurement cycle. The savings disappeared into expedite fees and staff hours.

2. Ignoring your own data. Your purchasing and clinical utilization data is the most underused asset you have. If you don't have a cost tracking system, build one. I built mine in Excel in 2019. That spreadsheet has saved us a ton of money — roughly $8,400 a year, about 17% of our wound care budget — by identifying waste patterns we never would have caught manually.

Before you sign: verify current facts

This guidance reflects my experience through Q1 2025. Medical device regulations and product portfolios change quickly. Verify current 510(k) clearances at FDA.gov and request updated ISO certificates directly from any supplier you're considering.

Whether you're evaluating Mölnlycke Health Care US or a smaller regional competitor, the checklist is the same: define the clinical need, verify the company, scrutinize the evidence, calculate true TCO, assess supply chain resilience, trial the product, and write a contract you can exit.

Take it from someone who learned this the expensive way: doing the homework upfront is way easier than explaining to your CFO why the "budget-friendly" vendor cost you double.